Antibiotic Drugs Flashcards
1
Q
Antibiotics: Peptidoglycan synthesis
A
- Beta Lactams
- Vancomycin
- Bacitracin
- Fosfomycin
- D cycloserine
2
Q
Antibiotic: rnap rna synthesis
A
- rifampin
- fidaxomicin
3
Q
Antibiotic: Key metabolic reactions
A
- trimethoprim
- sulfamethoxazole
4
Q
Antibiotic: Cell membrane
A
- polymyxins
- daptomycin
5
Q
Antibiotic: dna replication and repair
A
- fluoroquinolones
- metronidazoles
6
Q
Antibiotic: Ribosomes and protein synthesis
A
- tetracyclines
- aminoglycosides
- macrolides
- oxazolidinones
- clindamycin
- chloramphenicol
- tigecycline
7
Q
Peptidoglycan biosynthesis
A
- Syn MurNAc pentapeptide precursors (cyto)
- Lipid linkage; trans disaccharide precursors across membrane
- Polymerization catalyzed by PBPs and crosslinking (extracellular)
8
Q
Beta Lactams
A
- block peptidoglycan crosslinking via binding PBPs
- 4 families
- Penicillin (penicillin, ampicillin, amoxicillin, methicillin, oxacillin, ticarcillin, piperacillin)
- Cephalosporin (1st gen-cefazolin, cephalexin; 2nd gen-cefuroxime, cefoxitin; 3rd gen-cetriaxone, ceftazadime; 4th gen-cefepime) **4th gen is most broad spectrum
- Monobactam (aztreonam)
- Carbapenem (imipenem, meropenem, ertapenem, doripenem)
9
Q
Mechanisms of Resistance to Beta lactams (3)
A
- beta lactamASE production=inactivates beta lactam ring
- encoded in plasmid or chromosome
- primarily found in Gram NEGATIVE bacteria - decreased permeability = prevents beta lactam antibiotics from accessing PBPs
- altered PBPs = prevent binding of beta lactam antibiotics
- most common in Gram POSITIVE bacteria
10
Q
Overcoming Beta lactamase - use inhibitor
A
- beta lactamase inhibitors: clavulanic acid, sulbactam, tazobactam
- administer with beta lactam antibiotics
11
Q
Glycopeptides (vancomycin)
A
- peptidoglycan inhibitor
- bind D-Ala-D-Ala at end of peptide side chain in peptidoglycan precursor, thus PBPs can’t act
- effective on Gram POSITIVE not on gram negative
- **often used for beta lactam resistant infections (MRSA) or beta lactam hypersensitivity
12
Q
Cycloserine
A
- inhibits peptidoglycan crosslinking
- structure similar to D Alanine
- **used as second line antiTB therapy
13
Q
Bacitracin
A
- in the group that acts at peptidoglycan synthesis
- too toxic for systemic use; topical ointments (neosporin)
- binds to pyrophosphate on lipid carrier for peptidoglycan percursors and blocks recycling, thus peptidoglycan syn can’t continue
- Group A streptococci are 10x more sensitive than other bacteria
14
Q
Daptomycin
A
- lipid modified peptide
- bacteriocidal
- narrow spectrum, Gram POSITIVE bacteria
- bind/disrupt cyto memb
15
Q
Polymyxins
A
- lipopeptide
- narrow spectrum, Gram NEGATIVE bacteria
- adverse effects due to toxicity limits use
- binds to bacteria LPS in outer membrane